Find Press / Media

Search results

• Research on Environmental Health Discussed by Researchers at Universidad Industrial de Santander (Avoidable mortality due to long-term exposure to PM2.5 in Colombia 2014-2019)

  Víctor Mauricio Herrera Galindo

  9/01/23

  1 item of Media coverage

  Press/Media

• Researcher's Work from Universidad Industrial de Santander Focuses on Infectious Diseases and Conditions (2099. Clinical frailty scale as a predictor of mortality of pulmonary infections in patients with hematological malignancies)

  Miguel Oswaldo Cadena Sanabria

  4/01/23

  1 item of Media coverage

  Press/Media

• How the Chicago City Council election is shaping up: Who’s facing steep competition, and who’s getting a free pass

  Oscar Eduardo Rueda Sánchez

  5/12/22

  1 item of Media coverage

  Press/Media

• Alberto Montoya Puyana: "I am pleased to have been able to serve the community"

  Virgilio Galvis Ramírez

  22/04/21

  1 item of Media coverage

  Press/Media

• El Sistema General de Regalías, SGR, de Colombia, aportará 7.713.593.793...

  José Daniel Cabrera Cruz

  12/03/21

  1 item of Media coverage

  Press/Media

• Disorder and agglomerations at vaccination sites for older adults in Bucaramanga

  Paul Anthony Camacho López

  11/03/21

  1 item of Media coverage

  Press/Media

• Universidad inteligente: Factores claves para la adopción de internet de las cosas y big data /Smart university: Key factors for the adoption of internet of things and big data.

  César Darío Guerrero Santander

  1/03/21

  1 item of Media coverage

  Press/Media

• Colombian Society of Ophthalmology exalts two Santander doctors

  Virgilio Galvis Ramirez & Alejandro Tello Hernández

  17/08/20

  1 item of Media coverage

  Press/Media

• A recognition of his contribution in the development of radiology in Latin America

  Federico Guillermo Lubinus Badillo

  25/02/19

  1 item of Media coverage

  Press/Media

• Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Di

  Diego Luis Saaibi Solano

  2/10/18

  1 item of Media coverage

  Press/Media

• Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease; CREDO 2

  Diego Luis Saaibi Solano

  2/10/18

  1 item of Media coverage

  Press/Media

• Evaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.; MULTIBENZ

  Juan Carlos Villar Centeno

  2/10/18

  1 item of Media coverage

  Press/Media

• Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regimens of Olokizumab (OKZ), in Subjects With Rheumatoid Arthritis (RA) Who Previously Completed 24 Weeks of Blinded Treatment in One of the Core Studies - CREDO 1, 2 or 3.; CRED

  Diego Luis Saaibi Solano

  2/10/18

  1 item of Media coverage

  Press/Media

• CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY); CHICAMOCHA-3

  Juan Carlos Villar Centeno

  2/10/18

  1 item of Media coverage

  Press/Media

• Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery

  Juan Carlos Villar Centeno

  14/11/17

  1 item of Media coverage

  Press/Media

• Draw of Silicon Valley stronger than fear of Trump for international students

  Víctor Hugo Figueroa Arenas

  14/06/17

  4 items of Media coverage

  Press/Media